Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genetics of Cutaneous T Cell Lymphoma: From Bench to Bedside
William Damsky, Jaehyuk Choi
Current Treatment Options in Oncology (2016) Vol. 17, Iss. 7
Closed Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

JAK inhibitors in dermatology: The promise of a new drug class
William Damsky, Brett King
Journal of the American Academy of Dermatology (2017) Vol. 76, Iss. 4, pp. 736-744
Open Access | Times Cited: 430
Genomic analysis of 220 CTCLs identifies a novel recurrent gain-of-function alteration in RLTPR (p.Q575E)
Joonhee Park, Jingyi Yang, Alexander T. Wenzel, et al.
Blood (2017) Vol. 130, Iss. 12, pp. 1430-1440
Open Access | Times Cited: 149
Mycosis Fungoides and Sézary Syndrome
Cecilia Larocca, Thomas S. Kupper
Hematology/Oncology Clinics of North America (2018) Vol. 33, Iss. 1, pp. 103-120
Open Access | Times Cited: 113
Integrated genomic analyses of cutaneous T-cell lymphomas reveal the molecular bases for disease heterogeneity
Joonhee Park, Jay Daniels, Tim Wartewig, et al.
Blood (2021) Vol. 138, Iss. 14, pp. 1225-1236
Open Access | Times Cited: 72
Mycosis fungoides and Sézary syndrome: clinical presentation, diagnosis, staging, and therapeutic management
Denis Miyashiro, José Antônio Sanches
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 26
Panel Sequencing Shows Recurrent Genetic FAS Alterations in Primary Cutaneous Marginal Zone Lymphoma
Katja Maurus, Silke Appenzeller, Sabine Roth, et al.
Journal of Investigative Dermatology (2018) Vol. 138, Iss. 7, pp. 1573-1581
Open Access | Times Cited: 48
BET inhibition in advanced cutaneous T cell lymphoma is synergistically potentiated by BCL2 inhibition or HDAC inhibition
Sa Rang Kim, Julia M. Lewis, Benoit M. Cyrenne, et al.
Oncotarget (2018) Vol. 9, Iss. 49, pp. 29193-29207
Open Access | Times Cited: 47
SATB1 in Malignant T Cells
Simon Fredholm, Andreas Willerslev-Olsen, Özcan Met, et al.
Journal of Investigative Dermatology (2018) Vol. 138, Iss. 8, pp. 1805-1815
Open Access | Times Cited: 45
Romidepsin and Afatinib Abrogate Jak–Signal Transducer and Activator of Transcription Signaling and Elicit Synergistic Antitumor Effects in Cutaneous T-Cell Lymphoma
Bobby B. Shih, Cindy Ma, José R. Cortés, et al.
Journal of Investigative Dermatology (2024) Vol. 144, Iss. 7, pp. 1579-1589.e8
Open Access | Times Cited: 4
Novel cell adhesion/migration pathways are predictive markers of HDAC inhibitor resistance in cutaneous T cell lymphoma
Jared Andrews, Jennifer A. Schmidt, Kenneth R. Carson, et al.
EBioMedicine (2019) Vol. 46, pp. 170-183
Open Access | Times Cited: 31
Recent advances in understanding and managing cutaneous T-cell lymphomas
Patrick M. Brunner, Constanze Jonak, Robert Knobler
F1000Research (2020) Vol. 9, pp. 331-331
Open Access | Times Cited: 31
An Update on Molecular Biology of Cutaneous T Cell Lymphoma
Ritika Walia, Cecilia C.S. Yeung
Frontiers in Oncology (2020) Vol. 9
Open Access | Times Cited: 30
Jak-STAT Inhibition Mediates Romidepsin and Mechlorethamine Synergism in Cutaneous T-Cell Lymphoma
José R. Cortés, Christina C. Patrone, S. Aidan Quinn, et al.
Journal of Investigative Dermatology (2021) Vol. 141, Iss. 12, pp. 2908-2920.e7
Open Access | Times Cited: 21
Variations in genetics, biology, and phenotype of cutaneous disorders in skin of color – Part I: Genetic, biologic, and structural differences in skin of color
Jessica B. Brown-Korsah, Shanice A. McKenzie, Deega Omar, et al.
Journal of the American Academy of Dermatology (2022) Vol. 87, Iss. 6, pp. 1239-1258
Closed Access | Times Cited: 16
Ruxolitinib: A Review in Polycythaemia Vera
Kate McKeage
Drugs (2015) Vol. 75, Iss. 15, pp. 1773-1781
Closed Access | Times Cited: 28
Molecular Insights Into Pathogenesis of Peripheral T Cell Lymphoma: a Review
Waseem Lone, Aisha Alkhiniji, Jayadev Manikkam Umakanthan, et al.
Current Hematologic Malignancy Reports (2018) Vol. 13, Iss. 4, pp. 318-328
Closed Access | Times Cited: 24
Transcriptional Heterogeneity and the Microbiome of Cutaneous T-Cell Lymphoma
Philipp Licht, Volker Mailänder
Cells (2022) Vol. 11, Iss. 3, pp. 328-328
Open Access | Times Cited: 14
T-Cell Non-Hodgkin Lymphomas: Spectrum of Disease and the Role of Imaging in the Management of Common Subtypes
Hye Sun Park, Lacey J. McIntosh, Marta Braschi‐Amirfarzan, et al.
Korean Journal of Radiology (2017) Vol. 18, Iss. 1, pp. 71-71
Open Access | Times Cited: 22
Cell signaling in cutaneous T‐cell lymphoma microenvironment: promising targets for molecular‐specific treatment
Natalia Rendón‐Serna, Luis Alfonso Correa Londoño, Margarita María Velásquez‐Lopera, et al.
International Journal of Dermatology (2021) Vol. 60, Iss. 12, pp. 1462-1480
Closed Access | Times Cited: 16
Mycosis fungoides and Sézary syndrome
Constanze Jonak, Julia Tittes, Patrick M. Brunner, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2021) Vol. 19, Iss. 9, pp. 1307-1334
Open Access | Times Cited: 16
Understanding Cell Lines, Patient-Derived Xenograft and Genetically Engineered Mouse Models Used to Study Cutaneous T-Cell Lymphoma
Raman Preet Kaur Gill, Jennifer Gantchev, Amelia Martínez Villarreal, et al.
Cells (2022) Vol. 11, Iss. 4, pp. 593-593
Open Access | Times Cited: 12
The skin microbiome stratifies patients with cutaneous T cell lymphoma and determines event-free survival
Philipp Licht, Nazzareno Dominelli, Johannes Kleemann, et al.
npj Biofilms and Microbiomes (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Fusion of the genes ataxin 2 like, ATXN2L, and Janus kinase 2, JAK2, in cutaneous CD4 positive T-cell lymphoma
Ioannis Panagopoulos, Ludmila Gorunova, Signe Spetalen, et al.
Oncotarget (2017) Vol. 8, Iss. 61, pp. 103775-103784
Open Access | Times Cited: 19
Molecular pathogenesis of cutaneous lymphomas
Rudolf Stadler, R. Stranzenbach
Experimental Dermatology (2018) Vol. 27, Iss. 10, pp. 1078-1083
Open Access | Times Cited: 17
Role of cytokine in malignant T-cell metabolism and subsequent alternation in T-cell tumor microenvironment
Megha Yadav, Blessi N. Uikey, Shantnu Singh Rathore, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top